Company / Current Assets
Zoetis Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$6.8B
FY2025
5-year range
$6.0B / $7.5B
FY2021-FY2025
Trend
+13.1%
vs FY2024
Sector context
#14 of 213
Health Care
What the data says
Among 213 Health Care companies, Zoetis is in the top 7% for current assets. Current Assets returned to growth in FY2025 after 2 years of decline, reaching $6.8B.
Based on SEC 10-K filings.
$6.8B in FY2025 with a 5-year CAGR of +0.5%. Top quartile in the Health Care sector.
Improved from $6.3B to $6.8B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 213This company $6.8B Sector average $2.5B
▼
+168.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.5%, indicating consistent growth.
- In FY2025, current assets increased 13.1% year-over-year.
- Ranks #14 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.8B | +13.1% |
| FY2024 | $6.0B | -5.6% |
| FY2023 | $6.3B | -15.5% |
| FY2022 | $7.5B | +8.3% |
| FY2021 | $6.9B | +4.8% |
| FY2020 | $6.6B | +39.2% |
| FY2019 | $4.7B | +7.9% |
| FY2018 | $4.4B | +4.3% |
| FY2017 | $4.2B | +24.4% |
| FY2016 | $3.4B | -11.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026